Nanotechnology for computed tomography: A real potential recently discloseds

Pharmaceutical Research

Volumn 31, Issue 1, 2014, Pages 20-34

  Anton, Nicolas ^a   Vandamme, Thierry F ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

computed tomography; nano emulsion; nanoparticle; preclinical imaging; targeted imaging

Indexed keywords

CONTRAST MEDIUM; DENDRIMER; LIPOSOME; NANOCARRIER; NANOPARTICLE;

COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MICELLE; NANOEMULSION; NANOTECHNOLOGY; NONHUMAN; PHYSICAL CHEMISTRY; POLYMERIZATION; PRIORITY JOURNAL; PRODUCTIVITY; RADIOGRAPHY; REVIEW; SCALE UP;

ANIMALS; DIAGNOSTIC IMAGING; HUMANS; NANOSTRUCTURES; NANOTECHNOLOGY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84891635528     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-013-1131-3     Document Type: Review

References (137)

1. Badea CT, Drangova M, Holdsworth DW, Johnson GA. In vivo small-animal imaging using micro-ct and digital subtraction angiography. Phys Med Biol. 2008;53:R319-50.
2. Burghardt AJ, Link TM, Majumdar S. High-resolution computed tomography for clinical imaging of bone microarchitecture. Clin Orthop Relat Res. 2011;469:2179-93.
3. de Kemp RA, Epstein FH, Catana C, Tsui BMW, Ritman EL. Small-animal molecular imaging methods. J Nucl Med. 2010;51:18-32.
4. Weber E, Fernandez M, Wapner P, Hoffman W. Comparison of x-ray micro-tomography measurements of densities and porosity principally to values measured by mercury porosimetry for carbon-carbon composites. Carbon. 2010;48:2151-8.
5. Zagorchev L, Oses P, Zhuang ZW, Moodie K, Mulligan-Kehoe M, Simons M, et al. Micro computed tomography for vascular exploration. J Angiogenesis Res. 2010;2:7-17.
6. Schambach SJ, Bag S, Groden C, Schilling L, Brockmann MA. Vascular imaging in small rodents using micro-ct. Methods. 2010;50:26-35.
7. Ritman EL. Small-animal ct: Its difference from, and impact on, clinical ct. Nucl Instrum Methods Phys Res A. 2007;580:968-70. (Pubitemid 47385924)
8. Tsui BMW, Kraitchman DL. Recent advances in small-animal cardiovascular imaging. J Nucl Med. 2009;50:667-70.
9. Li J, Chaudhary A, Chmura SJ, Pelizzari C, Rajh T, Wietholt C, et al. A novel functional ct contrast agent for molecular imaging of cancer. Phys Med Biol. 2010;55:4389-97.
10. Graham KC, Wirtzfeld LA, MacKenzie LT, Postenka CO, Groom AC, MacDonald IC, et al. Three-dimensional high-frequency ultrasound imaging for longitudinal evaluation of liver metastases in preclinical models. Cancer Res. 2005;65:5231-7. (Pubitemid 40827333)
11. van Tellingen O, Beijnen J, Verweij J, Scherrenburg E, Nooijen W, Sparreboom A. Rapid esterase-sensitive breakdown of polysorbate 80 and its impact on the plasma pharmacokinetics of docetaxel and metabolites in mice. Clin Cancer Res. 1999;5:2918-24. (Pubitemid 29493971)
12. Storm G, Belliot SO, Daemen T, Lasic DD. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Deliv Rev. 1995;17:31-48.
13. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev. 2002;54:631-51. (Pubitemid 35247520)
14. Haley B, Frenkel E. Nanoparticles for drug delivery in cancer treatment. Urol Oncol. 2008;26:57-64.
15. Singh R, Lillard Jr JW. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009;86:215-23.
16. Torchilin VP, Trubetskoy VS. Which polymers can make nanoparticulate drug carriers long-circulating? Adv Drug Deliv Rev. 1995;16:141-55.
17. Ghaghada KB, Badea CT, Karumbaiah L, Fettig N, Bellamkonda RV, Johnson GA, et al. Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging. Acad Radiol. 2011;18:20-30.
18. Kao CY, Hoffman EA, Beck KC, Bellamkonda RV, Annapragada AV. Long-residence-time nano-scale liposomal iohexol for x-ray-based blood pool imaging. Acad Radiol. 2003;10:475-83. (Pubitemid 36534888)
19. Martiniova L, Schimel D, Lai EW, Limpuangthip A, Kvetnansky R, Pacak K. In vivo micro-ct imaging of liver lesions in small animal models. Methods. 2010;50:20-5.
20. Rabin O, Manuel Perez J, Grimm J, Wojtkiewicz G, Weissleder R. An x-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater. 2006;5:118-22. (Pubitemid 43177900)
21. Torchilin VP, Frank-Kamenetsky MD, Wolf GL. Ct visualization of blood pool in rats by using long-circulating, iodine-containing micelles. Acad Radiol. 1999;6:61-5. (Pubitemid 29061482)
22. Almajdub M, Nejjari M, Poncet G, Magnier L, Chereul E, Roche C, et al. In-vivo high-resolution x-ray microtomography for liver and spleen tumor assessment in mice. Contrast Media Mol Imaging. 2007;2:88-93. (Pubitemid 46863625)
23. Kim HW, Cai QY, Jun HY, Chon KS, Park SH, Byun SJ, et al. Micro-ct imaging with a hepatocyte-selective contrast agent for detecting liver metastasis in living mice. Acad Radiol. 2008;15:1282-90.
24. Ohta S, Lai EW, Morris JC, Bakan DA, Klaunberg B, Cleary S, et al. Microct for high-resolution imaging of ectopic pheochromocytoma tumors in the liver of nude mice. Int J Cancer. 2006;119:2236-41. (Pubitemid 44423688)
25. Havron A, Seltzer S, Davis MA, Shulkin P. Radiopaque liposomes: A promising new contrast material for computed tomography of the spleen. Radiology. 1981;140:507-11. (Pubitemid 11039987)
26. Ryan PJ, Davis MA, DeGaeta LR, Woda B, Meichior DL. Liposomes loaded with contrast material for image enhancement in computed tomograpy. Radiology. 1984;152:759-62. (Pubitemid 14060628)
27. Benita S, Poly P, Puisieux F, Delattre J. Radiopaque liposomes: effect of formulation conditions on encapsulation efficiency. J Pharm Sci. 1984;73(12):1751-5. (Pubitemid 15190930)
28. Seltzer SE, Blau M, Herman LW, Hooshmand RL, Herman LA, Adams DF, et al. Contrast material-carrying liposomes: Blodistributlon, clearance, and imaging characteristics. Radiology. 1995;194:775-81.
29. Zingel C, Sachse A, Ršssling GL, MÅ̧ller RH. Lyophilization and rehydration of iopromide-carrying liposomes. Int J Pharm. 1996;140:13-24. (Pubitemid 26276710)
30. Desser TS, Rubin DL, Muller H, McIntire GL, Bacon ER, Toner JL. Blood pool and liver enhancement in ct with liposomal iodixanol: Comparison with iohexol. Acad Radiol. 1999;6:176-83. (Pubitemid 32674968)
31. Schmiedl UP, Krause W, Leike J, Sachse A. Ct blood pool enhancement in primates with lopromide-carrying liposomes containing soy phosphatidyl glycerol. Acad Radiol. 1999;6:164-9. (Pubitemid 32674966)
32. Harrington KJ, Mohammadtaghi S, Uster PS, Glass D, Peters AM, Vile RG, et al. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin Cancer Res. 2001;7:243-54. (Pubitemid 32183025)
33. Leike JL, Sachse A, Rupp K. Characterization of continuously extruded iopromide-carrying liposomes for computed tomography blood-pool imaging. Investig radiol. 2001;36(6):303-8. (Pubitemid 32553413)
34. Leander P, Höglund P, Borseth A, Kloster Y, Berg A. A new liposomal liver-specific contrast agent for ct: first human phase-i clinical trial assessing efficacy and safety. Eur Radiol. 2001;11:698-704. (Pubitemid 32755513)
35. Mukundan Jr S, Ghaghada KB, Badea CT, Kao CY, Hedlund LW, Provenzale JM, et al. A liposomal nanoscale contrast agent for preclinical ct in mice. Am J Roentgenol. 2006;186:300-7. (Pubitemid 46100296)
36. Montet X, Pastor C, VallŽe JP, Becker C, Geissbuhler A, Morel D, et al. Improved visualization of vessels and hepatic tumors by micro-computed tomography (ct) using iodinated liposomes. Investig Radiol. 2007;42(9):652-8. (Pubitemid 47262934)
37. Burke SJ, Annapragada A, Hoffman EA, Chen E, Ghaghada KB, Sieren J, et al. Imaging of pulmonary embolism and t-pa therapy effects using mdct and liposomal iohexol blood pool agent. preliminary results in a rabbit model. Acad Radiol. 2007;14:355-62. (Pubitemid 46329456)
38. Zheng J, Liu J, Dunne M, Jaffray DA, Allen C. In vivo performance of a liposomal vascular contrast agent for ct and mr-based image guidance applications. Pharm Res. 2007;24(6):1193-201. (Pubitemid 46798881)
39. Badea C, Samei E, Ghaghada K, Saunders R, Yuan H, Qi Y, et al. Utility of a prototype liposomal contrast agent for x-ray imaging of breast cancer: a proof of concept using micro-ct in small animals. Proc Soc Photo Opt Instrum Eng. 2008;9:691303.1-691303.9.
40. Elrod DB, Partha R, Danila D, Casscells SW, Conyers JL. An iodinated liposomal computed tomographic contrast agent prepared from a diiodophosphatidylcholine lipid. Nanomed-Nanotechnol Biol Med. 2009;5:42-5.
41. Weichert JP, Longino MA, Bakan DA, Spigarelli MG, Chou T, Schwendner SW, et al. Polyiodinated triglyceride analogs as potential computed tomography imaging agents for the liver. J Med Chem. 1995;38:636-46.
42. Bakan DA, Longino MA, Weichert JP, Counsell RE. Physicochemical characterization of a synthetic lipid emulsion for hepatocyte-selective delivery of lipophilic compounds: Application to polyiodinated triglycerides as contrast agents for computed tomography. J Pharm Sci. 1996;85:908-14. (Pubitemid 26300214)
43. Lee Jr F, Chosy S, Naidu S, Goldfarb S, Weichert J, Bakan D, et al. Ct depiction of experimental liver tumors: Contrast enhancement with hepatocyte-selective iodinated triglyceride versus conventional techniques. Radiology. 1997;203(2):465-70. (Pubitemid 27176223)
44. Weichert J, Lee Jr F, Longino M, Chosy S, Counsell R. Lipid-based blood-pool ct imaging of the liver. Acad radiol. 1998;5:16-9.
45. Weichert JP, Lee FT, Chosy SG, Longino MA, Kuhlman JE, Heisey DM, et al. Combined hepatocyte-selective and blood-pool contrast agents for the ct detection of experimental liver tumors in rabbits. Radiology. 2000;216:865-71. (Pubitemid 30660867)
46. Weber SM, Peterson KA, Durkee B, Qi C, Longino M, Warner T, et al. Imaging of murine liver tumor using microct with a hepatocyte-selective contrast agent: accuracy is dependent on adequate contrast enhancement. J Surg Res. 2004;119:41-5. (Pubitemid 38581983)
47. Badea C, Fubara B, Hedlund L, Johnson G. 4-d micro-ct of the mouse heart. Mol Imaging. 2005;4(2):110-6. (Pubitemid 43143798)
48. Ford N, Graham K, Groom A, MacDonald I, Chambers A, Holdsworth D. Time-course characterization of the computed tomography contrast enhancement of an iodinated blood-pool contrast agent in mice using a volumetric flat-panel equipped computed tomography scanner. Investig Radiol. 2006;41(4):384-90. (Pubitemid 44284200)
49. Henning T, Weber AW, Bauer JS, Meier R, Carlsen JM, Sutton EJ, et al. Imaging characteristics of dhog, a hepatobiliary contrast agent for preclinical microct in mice. Acad Radiol. 2008;15:342-9. (Pubitemid 351232244)
50. Willekens I, Lahoutte T, Buls N, Vanhove C, Deklerck R, Bossuyt A, et al. Time-course of contrast enhancement in spleen and liver with exia 160, fenestra lc, and vc. Mol Imaging Biol. 2009;11:128-35.
51. Trubetskoy VS, Gazelle GS, Wolf GL, Torchilin VP. Block-copolymer of polyethylene glycol and polylysine as a carrier of organic iodine: design of long-circulating particulate contrast medium for x-ray computed tomography. J Drug Target. 1997;4:381-8. (Pubitemid 27296337)
52. Torchilin VP. Polymeric micelles in diagnostic imaging. Colloid Surf B-Biointerfaces. 1999;16:305-19.
53. Trubetskoy V. Polymeric micelles as carriers of diagnostic agents. Adv Drug Deliv Rev. 1999;37(1-3):81-8. (Pubitemid 29164501)
54. Torchilin V. Polymeric contrast agents for medical imaging. Curr Pharm Biotechnol. 2000;1(2):183-215.
55. Yordanov A, Mollov N, Lodder A, Woller E, Cloninger M, Walbridge S, et al. A water-soluble triiodo amino acid and its dendrimer conjugate for computerized tomography (ct) imaging. J Serb Chem Soc. 2005;70:163-70. (Pubitemid 43166593)
56. Yezhelyev MV, Gao X, Xing Y, Al-Hajj A, Nie S, OÕRegan RM. Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol. 2006;7:657-67. (Pubitemid 44143778)
57. Fu Y, Nitecki DE, Maltby D, Simon GH, Berejnoi K, Raatschen HJ, et al. Dendritic iodinated contrast agents with peg-cores for ct imaging: synthesis and preliminary characterization. Bioconjugate Chem. 2006;17:1043-56. (Pubitemid 44162625)
58. Ho Kong, W., Jae Lee, W., Yun Cui, Z., Hyun Bae, K., Gwan Park, T., Hoon Kim, J., Park, K., Won Seo, S.: Nanoparticulate carrier containing water-insoluble iodinated oil as a multifunctional contrast agent for computed tomography imaging. Biomaterials 28, 5555-5561 (2007) (Pubitemid 47599640)
59. Galperin A, Margel D, Baniel J, Dank G, Biton H, Margel S. Radiopaque iodinated polymeric nanoparticles for x-ray imaging applications. Biomaterials. 2007;28:4461-8. (Pubitemid 47212418)
60. Jakhmola A, Anton N, Vandamme T. Inorganic nanoparticles based contrast agents for x-ray computed tomography. Adv Healthcare Mater. 2012;1:413-31.
61. Storm G, Crommelin DA. Liposomes: quo vadis? PSTT. 1998;1:19-31. (Pubitemid 28234352)
62. Karathanasis E, Chan L, Balusu SR, DÕOrsi CJ, Annapragada AV, Sechopoulos I, et al. Multifunctional nanocarriers for mammographic quantification of tumor dosing and prognosis of breast cancer therapy. Biomaterials. 2008;29:4815-22.
63. Zheng J, Hoisak J, Allen C, Jaffray D. Longitudinal vascular imaging using a novel nano-encapsulated ct and mr contrast agent. Proc Soc Photo Opt Instrum Eng. 2007;6511(2):65,111-2.
64. Perkins G, Zheng J, Brock K, Allen C, Jaffray D. Nanoengineered multimodal contrast agent for medical imaging guidance. Proc Soc Photo Opt Instrum Eng. 2005;5746(1):31-9. (Pubitemid 41146236)
65. Allen T, Hansen C. Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim Biophys Acta. 1991;1068:122-41.
66. Klibanov A, Maruyama K, Bekerleg A, Torchilin V, Huang L. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim Biophys Acta. 1991;1062:142-8.
67. Maruyama K, Yuda T, Okamoto A, Kojima S, Suginaka A, Iwatsuru M. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatdylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim Biophys Acta. 1992;1128:44-9.
68. Torchilin V, Papisov M. Why do polyethylene glycol-coated liposomes circulate so long? J Liposome Res. 1994;4:725-39. (Pubitemid 24130567)
69. Phillips W, Klipper R, Awasthi V, Rudolph A, Cliff R, Kwasiborski V, et al. Polyethylene glycol modified liposome encapsulated hemoglobin: a long circulating red cell substitute. J Pharmacol Exp Ther. 1999;288:665-70. (Pubitemid 29119679)
70. Olson F, Hunt C, Szoka F, Vail W, Papahadjopoulos D. Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim Biophys Acta. 1979;557:9-23. (Pubitemid 10245657)
71. Szoka F, Olson F, Heath T, Vail W, Mayhew E, Papahadjopoulos D. Preparation of unilamellar liposomes of intermediate size (0.1-0.2 mm) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes. Biochim. Biophys. Acta. 1980;601:559-71.
72. Zheng J, Perkins G, Kirilova A, Allen C, Jaffray D. Multimodal contrast agent for combined computed tomography and magnetic resonance imaging applications. Invest Radiol. 2006;41(3):339-48. (Pubitemid 44406196)
73. Bourin M, Jolliet P, Ballereau F. An overview of the clinical pharmacokinetics of x-ray contrast media. Clin Pharmacokinet. 1997;32(3):180-93. (Pubitemid 27122519)
74. Drummond D, Meyer O, Hong K, Kirpotin D, Papahadjopoulous D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev. 1999;51(4):691-742.
75. Schneider T, Sachse A, Rossling G, Brandl M. Generation of contrast-carrying liposomes of defined size with a new continuous high pressure extrusion method. Int J Pharm. 1995;117:1-12.
76. Abra R, Hunt C. Liposome disposition in vivo. iii. dose and vesicle-size effects. Biochim Biophys Acta. 1981;666:493-503. (Pubitemid 12144883)
77. Hwang, K.: Liposome Pharmacokinetics, in Liposomes: From Biophysics to Therapeutics. Marcel Dekker (1987)
78. Senior J, Crawley J, Gregoriadis G. Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injection. Biochim Biophys Acta. 1985;839:1-8. (Pubitemid 15085295)
79. Gregoriadis G, Senior J. The phospholipid component of small unilamellar liposomes controls the rate of clearance of entrapped solutes from the circulation. FEBS Lett. 1980;119:43-6.
80. Jacobsen PB. Larsen, Konarboland, R., Skotland, T.: Biotransformation of nonionic x-ray contrast agents in vivo and in vitro. Drug Metab Dispos. 1999;27(10):1205-13. (Pubitemid 29463609)
81. Allen T, Murray L, MacKeigan S, Shah M. Chronic liposome administration in mice: Effects on reticuloendothelial function and tissue distribution. J Pharmacol Exp Ther. 1984;229:267-75. (Pubitemid 14082944)
82. Allen T, Smuckler E. Liver pathology accompanying chronic liposome administration in mouse. Res Commun Chem Pathol Pharmacol. 1985;50:281-90. (Pubitemid 16212440)
83. Allen T, Murray L, Alving C, Moe J. Effects of the murine mononuclear phagocyte system of chronic administration of liposomes containing cytotoxic drug or lipid a compared with empty liposomes. Can J Physiol Pharmacol. 1987;65:185-90. (Pubitemid 17047182)
84. Storm G, Oussoren C, Peeters P, Barenholz Y. Tolerability of liposomes in vivo, in Liposome Technology. FL: Boca Raton; 1993.
85. Mutzel W, Speck U. Tolerance and biochemical pharmacology of iopromide. Fortschr Gebiete Rontgenstrahlen Nuklearmedizin. 1983;118:11-7.
86. Kweon S, Lee HJ, Hyung WJ, Suh J, Lim JS, Lim SJ. Liposomes coloaded with iopamidol/lipiodol as a res-targeted contrast agent for computed tomography imaging. Pharm Res. 2010;27:1408-15.
87. Zheng J, Jaffray D, Allen C. Quantitative ct imaging of the spatial and temporal distribution of liposomes in a rabbit tumor model. Mol Pharm. 2009;6:571-80.
88. Karathanasis E, Suryanarayanan S, Balusu SR, McNeeley K, Sechopoulos I, Karellas A, et al. Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography. Radiology. 2009;250:398-406.
89. Samei E, Saunders RS, Badea CT, Ghaghada KB, Hedlund LW, Qi Y, et al. Micro-ct imaging of breast tumors in rodents using a liposomal, nanoparticle contrast agents. Int J Nanomed. 2009;4:277-82.
90. Wyss C, Schaefer SC, Juillerat-Jeanneret L, Lagopoulos L, Lehr HA, Becker CD, et al. Molecular imaging by micro-ct: specific e-selectin imaging. Eur Radiol. 2009;19:2487-94.
91. Austrup F, Vestweber D, Borges E, Lohning M, Brauer R, Herz U, et al. P- and e-selectin mediate recruitment of t-helper-1 but not t-helper-2 cells into inflamed tissues. Nature. 1997;385:81-3. (Pubitemid 27024558)
92. Graves BJ, Crowther RL, Chandran C, Rumberger JM, Li S, Huang KS, et al. Insight into e-selectin/ligand interaction from the crystal structure and mutagenesis of the lec/egf domains. Nature. 1994;367:532-8. (Pubitemid 24055510)
93. Anton N, Benoit JP, Saulnier P. Design and production of nanoparticles formulated from nano-emulsion templates - a review. J Control Release. 2008;128:185-99.
94. Anton N, Vandamme TF. The universality of low-energy nano-emulsification. Int J Pharm. 2009;377:142-7.
95. Anton N, Mojzisova H, Porcher E, Benoit JP, Saulnier P. Reverse micelle-loaded lipid nano-emulsions: New technology for nano-encapsulation of hydrophilic materials. Int J Pharm. 2010;398:204-9.
96. Anton N, Vandamme T. Nano-emulsions and micro-emulsions: Clarifications of the critical differences. Pharm Res. 2011;28:978-95.
97. Fryd M, Mason T. Advanced nanoemulsions Annu Rev Phys Chem. 2012;63:493-518.
98. McClements D. Nanoemulsions versus microemulsions: Terminology, differences, and similarities. Soft Matter. 2012;8:1719-29.
99. Hallouard F, Anton N, Choquet P, Constantinesco A, Vandamme T. Iodinated blood pool contrast media for preclinical x-ray imaging applications. Biomaterials. 2010;31:6249-68.
100. Hallouard F, Anton N, Zuber G, Choquet P, Li X, Arntz Y, et al. Radiopaque iodinated nano-emulsions for preclinical x-ray imaging. RSC Advances. 2011;1:792-801.
101. Hallouard, F., Briançon, S., Anton, N., Li, X., Vandamme, T., Fessi, H.: Iodinated nano-emulsions as contrast agents for preclinical x-ray imaging, impact of the free surfactants on the pharmacokinetics. Eur. J. Pharm. Biopharm. 2013;83:54-62.
102. Li X, Anton N, Zuber G, Zhao M, Hallouard F, Fessi H, et al. Iodinated α-tocopherol nano-emulsions as non-toxic contrast agents for preclinical x-ray imaging. Biomaterials. 2013;34:481-91.
103. Badea CT, Hedlund LW, de Lin M, Boslego Mackel JF, Johnson GA. Tumor imaging in small animals with a combined micro-ct/micro-dsa system using iodinated conventional and blood pool contrast agents. Contrast Media Mol Imaging. 2006;1:153-64.
104. Weichert JP, Groziak MP, Longino MA, Schwendner SW, Counsell RE. Potential tumor- or organ-imaging agents. 27. polyiodinated 1,3-disubstituted and 1,2,3-trisubstituted triacylglycerols. J Med Chem. 1986;29:2457-65. (Pubitemid 17211405)
105. Weichert JP, Longino MA, Schwendner SW, Counsell RE. Potential tumor- or organ-imaging agents. 26. polyiodinated 2-substituted triacylglycerols as hepatographic agents. J Med Chem. 1986;29:1674-82. (Pubitemid 16018194)
106. de Vries A, Custers E, Lub J, van den Bosch S, Nicolay K, Grüll H. Block-copolymer-stabilized iodinated emulsions for use as ct contrast agents. Biomaterials. 2010;31:6537-44.
107. Aprahamian M, Bour G, Akladios CY, Fylaktakidou K, Greferath R, Soler L, et al. Myo-inositoltrispyrophosphate treatment leads to hif-1α suppression and eradication of early hepatoma tumors in rats. ChemBioChem. 2011;12:777-83.
108. Guo R, Wang H, Peng C, Shen M, Pan M, Cao X, et al. X-ray attenuation property of dendrimer-entrapped gold nanoparticles. J Phys Chem C. 2009;114:50-6.
109. Kojima C, Umeda Y, Ogawa M, Harada A, Magata Y, Kono K. X-ray computed tomography contrast agents prepared by seeded growth of gold nanoparticles in pegylated dendrimer. Nanotechnology. 2010;21:245,104.
110. Peng C, Wang H, Guo R, Shen M, Cao X, Zhu M, et al. Acetylation of dendrimer-entrapped gold nanoparticles: Synthesis, stability, and x-ray attenuation properties. J Appl Polym Sci. 2011;119:1673-82.
111. Peng C, Zheng L, Chen Q, Shen M, Guo R, Wang H, et al. Pegylated dendrimer-entrapped gold nanoparticles for in vivo blood pool and tumor imaging by computed tomography. Biomaterials. 2012;33:1107-19.
112. Boote E, Fent G, Kattumuri V, Casteel S, Katti K, Chanda N, et al. Gold nanoparticle contrast in a phantom and juvenile swine: models for molecular imaging of human organs using x-ray computed tomography. Acad Radiol. 2010;17:410-7.
113. Kattumuri V, Katti K, Bhaskaran S, Boote EJ, Casteel SW, Fent GM, et al. Gum arabic as a phytochemical construct for the stabilization of gold nanoparticles: in vivo pharmacokinetics and x-ray-contrast-imaging studies. Small. 2007;3:333-41.
114. de Krafft KE, Xie Z, Cao G, Tran S, Ma L, Zhou OZ, et al. Iodinated nanoscale coordination polymers as potential contrast agents for computed tomography. Angew Chem-Int Edit. 2009;48:9901-4.
115. Bosman AW, Janssen HM, Meijer EW. About dendrimers: structure, physical properties, and applications. Chem Rev. 1999;99:1665-88. (Pubitemid 129585157)
116. Koo OM, Rubinstein I, Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomed-Nanotechnol Biol Med. 2005;1:193-212. (Pubitemid 43963632)
117. Guo R, Wang H, Peng C, Shen M, Zheng L, Zhang G, et al. Enhanced x-ray attenuation property of dendrimer-entrapped gold nanoparticles complexed with diatrizoic acid. J Mater Chem. 2011;21:5120-7.
118. Roberts J, Bhalgat M, Zera R. Preliminary biological evaluation of polyamidoamine (pamam) starburst dendrimers. J Biomed Mater Res. 1996;30(1):53-65.
119. Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener J, et al. Dendrimers: Relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of i-labelled polyamidoamine dendrimers in vivo. J Control Release. 2000;65(1-2):133-48. (Pubitemid 30122922)
120. Zinselmeyer B, Mackay S, Schatzlein A, Uchegbu I. The lower-generation polypropylenimine dendrimers are effective gene-transfer agents. Pharm Res. 2002;19(7):960-7. (Pubitemid 34808705)
121. Gajbhiye V, Vijayaraj Kumar P, Tekade R, Jain N. Pegylated ppi dendritic architectures for sustained delivery of h2 receptor antagonist. Eur J Med Chem. 2009;44(3):1155-66.
122. Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release. 2001;73:137-72. (Pubitemid 32544594)
123. Lukyanov AN, Torchilin VP. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv Drug Deliv Rev. 2004;56:1273-89. (Pubitemid 38510474)
124. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small. 2005;1:325-7. (Pubitemid 43951781)
125. Dalsin JL, Hu BH, Lee BP, Messersmith PB. Mussel adhesive protein mimetic polymers for the preparation of nonfouling surfaces. J Am Chem Soc. 2003;125:4253-8. (Pubitemid 36512318)
126. Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM. Gold nanoparticles: a new x-ray contrast agents. Br J Radiol. 2006;79:248-53.
127. Hiebert L. The uptake of heparin by liver sinusoidal cells in normal and atherosclerotic rabbits. Thromb Res. 1981;21:383-90. (Pubitemid 11117037)
128. Kim D, Park S, Lee JH, Jeong YY, Jon S. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo x-ray computed tomography imaging. J Am Chem Soc. 2007;129:7661-5. (Pubitemid 46981930)
129. Park K, Kim K, Kwon IC, Kim SK, Lee S, Lee DY, et al. Preparation and characterization of self-assembled nanoparticles of heparin-deoxycholic acid conjugates. Langmuir. 2004;20:11726-11731. (Pubitemid 40049648)
130. Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, Sastry M. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir. 2005;21:10644-10654. (Pubitemid 41692144)
131. Cai QY, Kim SH, Choi KS, Kim SY, Byun SJ, Kim KW, et al. Colloidal gold nanoparticles as a blood-pool contrast agent for x-ray computed tomography in mice. Invest Radiol. 2007;42:797-806. (Pubitemid 350126561)
132. Sun I, Eun D, Na JH, Lee S, Kim I, Youn I, et al. Heparin-coated gold nanoparticles for liver-specific ct imaging. Chem-Eur J. 2009;15:13341-13347.
133. Eck W, Nicholson AI, Zentgraf H, Semmler W, Bartling S. Anti-cd4-targeted gold nanoparticles induce specific contrast enhancement of peripheral lymph nodes in x-ray computed tomography of live mice. Nano Lett. 2010;10:2318-22.
134. Chanda N, Kattumuri V, Shukla R, Zambre A, Katti K, Upendran A, et al. Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity. Proc Natl Acad Sci USA. 2010;107:8760-5.
135. Zhang Z, Ross RD, Roeder RK. Preparation of functionalized gold nanoparticles as a targeted x-ray contrast agent for damaged bone tissue. Nanoscale. 2010;2:582-6.
136. Hainfeld JF, O'Connor MJ, Dilmanian FA, Slatkin DN, Adams DJ, Smilowitz HM. Micro-ct enables microlocalisation and quantification of her2-targeted gold nanoparticles within tumour regions. Br J Radiol. 2011;84:526-33.
137. Boll H, Nittka S, Doyon F, Neumaier M, Marx A, Kramer M, et al. Micro-ct based experimental liver imaging using a nanoparticulate contrast agent: A longitudinal study in mice. PLoS ONE. 2011;6(e25):1-6.